Relmada Therapeutics IncNASDAQ:RLMD
- LAST PRICE3.4200
- TODAY'S CHANGE (%)-0.0700 (-2.0057%)
- Bid / Lots3.3500/ 3
- Ask / Lots3.4900/ 1
- Open / Previous Close3.5000 / 3.4900
- Day Range
- 52 Week Range
- Volume114,042
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RLMD |
|---|---|---|
| 09:32 ET | 1332 | 3.595 |
| 09:33 ET | 533 | 3.575 |
| 09:35 ET | 100 | 3.64 |
| 09:37 ET | 200 | 3.56 |
| 09:39 ET | 1790 | 3.465 |
| 09:42 ET | 200 | 3.44 |
| 09:44 ET | 200 | 3.45 |
| 09:48 ET | 200 | 3.41 |
| 09:50 ET | 791 | 3.4183 |
| 09:51 ET | 100 | 3.45 |
| 09:55 ET | 200 | 3.42 |
| 09:57 ET | 200 | 3.42 |
| 10:00 ET | 500 | 3.43 |
| 10:02 ET | 800 | 3.45 |
| 10:04 ET | 100 | 3.42 |
| 10:06 ET | 100 | 3.455 |
| 10:09 ET | 2470 | 3.47 |
| 10:11 ET | 200 | 3.46 |
| 10:15 ET | 200 | 3.47 |
| 10:18 ET | 200 | 3.42 |
| 10:20 ET | 100 | 3.455 |
| 10:24 ET | 400 | 3.465 |
| 10:29 ET | 200 | 3.44 |
| 10:31 ET | 2921 | 3.46 |
| 10:33 ET | 100 | 3.47 |
| 10:38 ET | 100 | 3.475 |
| 10:44 ET | 200 | 3.46 |
| 10:56 ET | 400 | 3.45 |
| 11:00 ET | 200 | 3.46 |
| 11:03 ET | 400 | 3.48 |
| 11:12 ET | 300 | 3.495 |
| 11:18 ET | 11240 | 3.4 |
| 11:23 ET | 400 | 3.47 |
| 11:25 ET | 500 | 3.47 |
| 11:30 ET | 100 | 3.43 |
| 11:32 ET | 100 | 3.42 |
| 11:34 ET | 100 | 3.42 |
| 11:36 ET | 863 | 3.42 |
| 11:38 ET | 300 | 3.395 |
| 11:43 ET | 300 | 3.41 |
| 11:45 ET | 1127 | 3.405 |
| 11:48 ET | 500 | 3.4 |
| 11:54 ET | 700 | 3.43 |
| 11:56 ET | 200 | 3.43 |
| 11:57 ET | 100 | 3.43 |
| 12:03 ET | 100 | 3.43 |
| 12:06 ET | 200 | 3.425 |
| 12:08 ET | 300 | 3.425 |
| 12:10 ET | 100 | 3.425 |
| 12:12 ET | 200 | 3.4 |
| 12:15 ET | 200 | 3.425 |
| 12:19 ET | 979 | 3.441 |
| 12:24 ET | 300 | 3.42 |
| 12:39 ET | 200 | 3.415 |
| 12:42 ET | 770 | 3.4 |
| 12:51 ET | 200 | 3.44 |
| 12:53 ET | 200 | 3.43 |
| 12:55 ET | 600 | 3.42 |
| 01:06 ET | 600 | 3.4 |
| 01:11 ET | 100 | 3.42 |
| 01:15 ET | 100 | 3.42 |
| 01:20 ET | 100 | 3.41 |
| 01:22 ET | 100 | 3.41 |
| 01:24 ET | 100 | 3.405 |
| 01:31 ET | 800 | 3.405 |
| 01:33 ET | 2340 | 3.45 |
| 01:36 ET | 5041 | 3.44 |
| 01:38 ET | 200 | 3.48 |
| 01:42 ET | 1960 | 3.485 |
| 01:44 ET | 300 | 3.4995 |
| 01:45 ET | 9873 | 3.48 |
| 01:47 ET | 327 | 3.48 |
| 01:49 ET | 200 | 3.48 |
| 01:51 ET | 500 | 3.48 |
| 01:54 ET | 100 | 3.48 |
| 01:56 ET | 100 | 3.475 |
| 01:58 ET | 400 | 3.47 |
| 02:00 ET | 800 | 3.46 |
| 02:05 ET | 300 | 3.43 |
| 02:09 ET | 100 | 3.405 |
| 02:14 ET | 100 | 3.405 |
| 02:16 ET | 100 | 3.42 |
| 02:20 ET | 500 | 3.43 |
| 02:21 ET | 700 | 3.415 |
| 02:25 ET | 100 | 3.4 |
| 02:27 ET | 100 | 3.41 |
| 02:30 ET | 149 | 3.41 |
| 02:32 ET | 100 | 3.41 |
| 02:34 ET | 600 | 3.4 |
| 02:38 ET | 3592 | 3.4 |
| 02:39 ET | 100 | 3.38 |
| 02:45 ET | 100 | 3.38 |
| 02:48 ET | 412 | 3.36 |
| 02:50 ET | 100 | 3.37 |
| 02:52 ET | 225 | 3.39 |
| 02:54 ET | 700 | 3.41 |
| 02:56 ET | 100 | 3.41 |
| 02:57 ET | 200 | 3.41 |
| 03:01 ET | 100 | 3.41 |
| 03:03 ET | 600 | 3.41 |
| 03:10 ET | 100 | 3.405 |
| 03:14 ET | 300 | 3.395 |
| 03:15 ET | 2300 | 3.395 |
| 03:17 ET | 240 | 3.395 |
| 03:19 ET | 200 | 3.385 |
| 03:21 ET | 3125 | 3.4 |
| 03:24 ET | 960 | 3.4 |
| 03:26 ET | 200 | 3.42 |
| 03:28 ET | 700 | 3.43 |
| 03:30 ET | 200 | 3.41 |
| 03:32 ET | 200 | 3.42 |
| 03:33 ET | 100 | 3.43 |
| 03:35 ET | 205 | 3.41 |
| 03:37 ET | 400 | 3.405 |
| 03:39 ET | 700 | 3.4 |
| 03:44 ET | 500 | 3.4 |
| 03:46 ET | 420 | 3.42 |
| 03:48 ET | 3186 | 3.45 |
| 03:50 ET | 300 | 3.445 |
| 03:51 ET | 1149 | 3.43 |
| 03:53 ET | 400 | 3.425 |
| 03:55 ET | 1303 | 3.43 |
| 03:57 ET | 1204 | 3.42 |
| 04:00 ET | 2574 | 3.42 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Relmada Therapeutics Inc | 105.3M | -1.2x | --- |
Regencell Bioscience Holdings Ltd | 105.3M | -24.6x | --- |
Immunic Inc | 107.2M | -0.8x | --- |
Alto Neuroscience Inc | 107.3M | --- | --- |
Adicet Bio Inc | 103.0M | -0.5x | --- |
Genenta Science SPA | 99.3M | -10.0x | --- |
Company Information
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company addressing diseases of the central nervous system (CNS), with a focus on major depressive disorder (MDD). The Company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Esmethadone, an isomer of methadone, is a new chemical entity (NCE) that potentially addresses areas of high unmet medical need in the treatment of central nervous system (CNS) diseases and other disorders. The Company’s lead program, REL-1017, is a NCE and novel NMDA receptor (NMDAR) channel blocker that preferentially targets hyperactive channels while maintaining physiological glutamatergic neurotransmission. REL-1017 is in late-stage development as an adjunctive treatment for MDD in adults. Its esmethadone, is being developed as a rapidly acting, oral agent for the treatment of depression and other potential indications.
Contact Information
- Headquarters
- 2222 Ponce De Leon Blvd. 3Rd FloorCORAL GABLES, FL, United States 33134
- Phone
- 646-876-3459
- Fax
- ---
Executives
- Independent Chairman of the Board
- Charles Casamento
- Chief Executive Officer, Director
- Sergio Traversa
- Chief Financial Officer
- Maged Shenouda
- Chief Accounting, Compliance Officer
- Charles Ence
- Acting Chief Scientific Officer
- Paolo Manfredi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $105.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 30.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $-2.88 |
Book Value | $2.84 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
